Back To: Home : Featured Technology : Stem Cell

CLICK HERE FOR WHAT'S NEW IN:
 

Cell lines for human embryonic stem cell research
June 2007
SHARING OPTIONS:

Millipore Corp. announced the availability of their MEL cell lines—licensed, low-passage, human embryonic (hES) stem cells used in research for the treatment and potential cure of disabling and terminal diseases and conditions. The MEL-1 and MEL-2 hES cell lines have been extensively tested with Millipore's HEScGRO media for hES cell culture and are a valuable addition to Millipore's range of products for hES cell research. The MEL cell lines, derived by Stem Cell Sciences Ltd. in collaboration with Melbourne IVF and the Australian Stem Cell Centre, are under license from the Australian National Health and Medical Research Council. An agreement between Millipore and the Australian Stem Cell Centre in June 2006 made it possible for Millipore to distribute and market these stem cell lines in all countries outside of Australia. The MEL cell lines are provided at early passage (p10–p12), ideal for maximizing the stable lifespan of the cell line and ensuring extended research time in a stable, pluripotent state.  Late passage cell lines can have a limited workable shelf-life as karyotype stability may decrease and pluripotent characteristics may shift to reflect a multipotent state. The MEL cell lines grow as well defined colonies, with compact cells displaying high nuclear to cytoplasmic ratios and prominent nucleoli.
 
Millipore Corp.
800-645-5476

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.